Emendo Biotherapeutics vs Synthego
Emendo Biotherapeutics vs Synthego, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Emendo Biotherapeutics is on 59/100 and Synthego on 22/100.
Where each one leads
Emendo Biotherapeutics
- our overall score: 59/100 against 22/100
Synthego
- agent readiness: 45/100 against 40/100
- domain rating: 63/100 against 20/100
- headcount: 173 against 41
- LinkedIn following: 30,779 against 5,333
At a glance
| Measure | Emendo Biotherapeutics | Synthego |
|---|---|---|
| What it is | Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology. | Synthego provides engineered CRISPR gene editing tools and services for life sciences research. |
| Category | Healthcare, Genome Editing, CRISPR, Biotech | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2015 | 2013 |
| Headquarters | Tel Aviv, Israel | Redwood City, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Emendo Biotherapeutics | Synthego |
|---|---|---|
| Employees | 41 | 173 |
| Headcount growthLast 12 months | -16.1% | Not published |
| Total funding | $61.0M | Not published |
| Latest round | Series B | Not published |
| LinkedIn followers | 5,333 | 30,779 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Emendo Biotherapeutics | Synthego |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 22/100 |
| Traction | 55/100 | 20/100 |
| Team | 40/100 | Not published |
| Search visibility | 44/100 | 23/100 |
| Quality | 68/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (40/100) | D (45/100) |
| Domain ratingLink authority, 0-100 | 20/100 | 63/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Emendo Biotherapeutics | Synthego |
|---|---|---|
| Hosting | Google Cloud | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Bootstrap | Jquery, Bootstrap |
| Analytics | Google Tag Manager | Google Tag Manager |
| Support stack | Not detected | HubSpot |
Emendo Biotherapeutics vs Synthego: common questions
Which is better, Emendo Biotherapeutics or Synthego?
On our 0-100 score Emendo Biotherapeutics rates higher (59/100 against 22/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Emendo Biotherapeutics and Synthego compare on the numbers?
Emendo Biotherapeutics leads on our overall score (59/100 against 22/100). Synthego leads on agent readiness (45/100 against 40/100), domain rating (63/100 against 20/100), headcount (173 against 41), LinkedIn following (30,779 against 5,333).
Read the full Emendo Biotherapeutics review and pricing or the Synthego review and pricing. You can also browse other Emendo Biotherapeutics alternatives we track.

